|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 1 March 2006
doi: 10.1242/dev.02305
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



1 Victor Chang Cardiac Research Institute, Darlinghurst, Sydney 2010,
Australia.
2 Faculties of Life Science and Medicine, University of New South Wales,
Randwick 2031, Australia.
3 Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de
Janeiro, 20941-000, Brazil.
¶ Author for correspondence (e-mail: r.harvey{at}victorchang.unsw.edu.au)
Accepted 31 January 2006
Homeodomain factor Nkx2-5 is a central component of the transcription
factor network that guides cardiac development; in humans, mutations in
NKX2.5 lead to congenital heart disease (CHD). We have genetically
defined a novel conserved tyrosine-rich domain (YRD) within Nkx2-5 that has
co-evolved with its homeodomain. Mutation of the YRD did not affect DNA
binding and only slightly diminished transcriptional activity of Nkx2-5 in a
context-specific manner in vitro. However, the YRD was absolutely essential
for the function of Nkx2-5 in cardiogenesis during ES cell differentiation and
in the developing embryo. Furthermore, heterozygous mutation of all nine
tyrosines to alanine created an allele with a strong dominant-negative-like
activity in vivo: ES cell
embryo chimaeras bearing the heterozygous
mutation died before term with cardiac malformations similar to the more
severe anomalies seen in NKX2.5 mutant families. These studies
suggest a functional interdependence between the NK2 class homeodomain and YRD
in cardiac development and evolution, and establish a new model for analysis
of Nkx2-5 function in CHD.
Key words: Heart, Homeodomain, Nkx2-5, Congenital heart disease
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?